FLOTYL K GRESHAM

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SOMERVILLE, TN NPI 1306133848

General Payments — all program years on this page

$947.17

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $849.51 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $849.5117

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $551.568
Lilly USA, LLC $111.951
Novo Nordisk AS $57.953
Lundbeck LLC $44.472
Astellas Pharma US Inc $29.641
Otsuka America Pharmaceutical, Inc. $29.241
GlaxoSmithKline, LLC. $24.701

By program year

Program yearAmountRecords
2021 $14.761
2023 $82.904
2024 $849.5117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100424831 Novo Nordisk Inc $18.90 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100568504 Novo Nordisk Inc $24.23 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100610904 Novo Nordisk Inc $14.82 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104583146 AstraZeneca Pharmaceuticals LP $113.92 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104668841 AstraZeneca Pharmaceuticals LP $24.61 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105485085 AstraZeneca Pharmaceuticals LP $127.88 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105511967 AstraZeneca Pharmaceuticals LP $18.74 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105554754 AstraZeneca Pharmaceuticals LP $20.71 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105627967 AstraZeneca Pharmaceuticals LP $118.88 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105644062 AstraZeneca Pharmaceuticals LP $14.87 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105701522 AstraZeneca Pharmaceuticals LP $111.95 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116395980 GlaxoSmithKline, LLC. $24.70 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119084442 Otsuka America Pharmaceutical, Inc. $29.24 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135671688 Lilly USA, LLC $111.95 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139519967 Astellas Pharma US Inc $29.64 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146029068 Lundbeck LLC $22.09 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146029070 Lundbeck LLC $22.38 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.